Black Rock Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,446,366 shares of REGN stock, worth $4.7 Billion. This represents 0.2% of its overall portfolio holdings.
Number of Shares
8,446,366
Previous 8,568,654
1.43%
Holding current value
$4.7 Billion
Previous $8.25 Billion
7.64%
% of portfolio
0.2%
Previous 0.19%
Shares
13 transactions
Others Institutions Holding REGN
# of Institutions
1,411Shares Held
88.7MCall Options Held
1.96MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.24 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.15 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.69 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.13 Billion1.21% of portfolio
-
Capital International Investors Los Angeles, CA3.17MShares$1.76 Billion0.3% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...